New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial
Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
Read more on NPR
Health & Science - May 18, 2020 at 11:46PM - New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial
Không có nhận xét nào:
Đăng nhận xét